Analysis | Most CEOS are ‘rightfully afraid of Twitter’ — not Elon Musk

Brasil Notícia Notícia

Analysis | Most CEOS are ‘rightfully afraid of Twitter’ — not Elon Musk
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 washingtonpost
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 72%

Analysis: Most CEOS are 'rightfully afraid of Twitter' — not Elon Musk

The Securities and Exchange Commission says Elon Musk has broken a deal to have any potentially market-moving tweets about the electric vehicle company reviewed before letting them fly. By Jena McGregor Jena McGregor Reporter covering leadership issues in the headlines Email Bio Follow February 26 at 4:08 PM It’s an understatement to say that Tesla CEO Elon Musk’s tweeting is different from perhaps that of any other public company CEO.

” Tweets are not meant to sound like a news release, and a certain level of personality needs to show through for a tweet to resonate and be effective — a tricky balancing act for CEOs, who are often conservative. Schiller points to the battle that erupted between Twitter CEO Jack Dorsey and Salesforce co-CEO Marc Benioff over a San Francisco ballot measure to help the homeless. “That felt very authentic and demonstrated a very savvy use of Twitter,” Schiller said.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

washingtonpost /  🏆 95. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

SEC’s Tussle With Tesla’s Elon Musk Shows Challenge of Regulating Iconic CEOsSEC’s Tussle With Tesla’s Elon Musk Shows Challenge of Regulating Iconic CEOsThe latest legal action between U.S. securities regulators and Tesla Chief Executive Elon Musk highlights the challenge facing regulators and boards when it comes to reining in a wealthy chief executive whose identity is closely tied to the value of the company he or she leads.
Consulte Mais informação »

Live Analysis: Drug-Company CEOs Take the Hot Seat Before CongressRising drug prices will be in the spotlight as pharmaceutical industry executives testify before the Senate Finance Committee, where lawmakers are expected to ask executives from firms such as Merck and Pfizer about their pricing practices and other issues.
Consulte Mais informação »

Pharmaceutical Industry CEOs Face Senate Hearing on Drug PricesExecutives for some of the biggest drug companies will visit Capitol Hill on Tuesday to face tough questions in a Senate hearing on the rising cost of medicines.
Consulte Mais informação »

These are the top executives in EuropeInstitutional Investor ranked the continent's best CEOs, CFOs, and investor relations professionals across 31 industries.
Consulte Mais informação »

Drugmakers’ CEOs clash with senators in hearing on drug price hikesDrugmakers’ CEOs clash with senators in hearing on drug price hikesExecutives from seven pharmaceutical giants endure grillings but also push back Tuesday on Capitol Hill, as they testify before the Senate Finance Committee about rising drug prices.
Consulte Mais informação »

Pharmaceutical Company CEOs Face Grilling in Senate Over High Drug PricesPharmaceutical Company CEOs Face Grilling in Senate Over High Drug PricesLawmakers criticized pharmaceutical industry leaders during Senate testimony Tuesday, for failing to put patients before profits. The executives deflected blame over high drug prices to insurance companies and middlemen.
Consulte Mais informação »

The 25 CEOs whose pay is most wildly out of sync with their company's performanceThe 25 CEOs whose pay is most wildly out of sync with their company's performanceCheck out which 25 CEOs earn a salary that's higher than expected given shareholder return, according to a report from As You Sow.
Consulte Mais informação »



Render Time: 2025-03-04 13:09:05